Effect of Isoprinosine on Lymphocyte Proliferation and Natural Killer Cell Activity Following Thermal Injury

References

• Ninnemann J. L. Injury, Infection and the Immune Response. Clinical Immunology Newsletter 1984; 5: 173
   Google Scholar
• Baker C. C., Miller C. L., Trunkey D. D. Predicting Fatal Sepsis in Burn Patients. J. Trauma 1979; 19: 641
   PubMedGoogle Scholar
• McIrvine A. J., O'Mahoney J. B., Saporoschetz I., Mannick J. Depressed Immune Response in Burn Patients: Use of Monoclonal Antibodies and Functional Assays to Define the Role of Suppressor Cells. Ann. Surg. 1984; 196: 297
   Google Scholar
• Antonacci A. C., Reaves L. E., Calvano S. E., Armand R., DeRieshal H. F., Shires T. Flow Cytometric Analysis of Lymphocyte Subpopulations after Thermal Injury in Human Beings. Surg. Gynecol. Obstet. 1984; 159: 107
   Google Scholar
• Wolfe N., Saporoschetz A. B., Young A. E., O'Conner N. E., Mannick J. A. Suppressive Serum, Suppressor Lymphocyte, and Death from Burns. Ann. Surg. 1984; 193: 513
   Google Scholar
• Wood J., Roderick M. L., Palder S. B., Saporoschetz I., D'Eon P., Mannick J. A. Inadequate Interleukin-2 Production: A Fundamental Immunological Deficiency in Patients with Major Burns. Ann. Surg. 1984; 200: 311
   PubMedGoogle Scholar
• Ozkan A. N., Ninnemann J. L. Suppression of in vitro Lymphocyte and Neutrophil Responses by a Low Molecular Weight Suppressor Active Peptide from Burn Patient Sera. J. Clin. Immunol 1985; 5: 172
   PubMedGoogle Scholar
• Constentian M. B. Association of Sepis with an Immunosuppressive Polypeptide in the Serum of Burn Patients. Ann. Surg. 1978; 188: 209
   PubMedGoogle Scholar
• Singh H., Herndon D. N., Stein M. D. Kinetics of lympho-proliferative Responses following Scald Injury in a Rat Burn Model. Clin. Immunol. Immunopathol 1986; 40: 476
   PubMedGoogle Scholar
• Singh H., Berg N., Herndon D. N. Effect of Topical Application of Silver Sulfadiazene on the Natural Killer Cell Active in a Rat Model of Thermal Injury. J. Burn Care Rehab. 1988; 9: 152
   PubMedGoogle Scholar
• Ginsberg T., Glesky A. J. Inosiplex: An Immunomodulation Model for the Treatment of Viral Disease. Ann. N.Y. Acad. Sci. 1977; 284: 128
   PubMedGoogle Scholar
• Hadden J. W., Hadden E. M., Coffey R. G. Isoprinosine Augmentation of Phytohaemagglutinin Induced Lymphocyte Proliferation. Infect. Immunity 1976; 13: 382
   PubMedGoogle Scholar
• Rey A., Cupissol D. Thiersy. Modulation of Human T Lymphocyte Function by Isoprinosine. Int. J. Immunopharmacol. 1983; 5: 99
   PubMed Web of Science ®Google Scholar
• Tsang K. Y., Fudenberg H. H., Pam J. F., Gnagy M. J., Bristow C. B. An in vitro Study of the Effects of Isoprinosine on Immune Response in Cancer Patients. Int. J. Immunopharmacol. 1983; 5: 481
   PubMedGoogle Scholar
• Tsang K. Y., Pan J. F., Swanger D. L., Fudenberg H. H. In vitro Restoration of Immune Responses in Aging Huans by Isoprinosine. Int. J. Immunopharmacol. 1985; 7: 199
   PubMed Web of Science ®Google Scholar
• Tsang K. Y., Fredenberg H. H., Gnagy M. J. Restoration of Immune Responses of Aging Hamsters by Treatment with Isoprinosine. J. Clin. Invest. 1983; 71: 1750
   PubMed Web of Science ®Google Scholar
• Tsang K. Y., Fudenberg H. H., Galbraith G. M.P., Donnelly R. P., Bishop L. R., Koopmann W. R. Partial Restoration of Impaired Interleukin-2 Production and Tac Antigen (Putative Interleuk.in-2 Receptor) Expression in Patients with Acquired Immune Deficiency Syndrome by Isoprinosine Treatment in vitro J. Clin. Invest. 1985; 75: 1538
   Google Scholar
• Donati L., Lazzarin A., Signorini M., Candiani P., Klin-Ger M., Moroni M. Preliminary Clinical Experience with the Use of Immunomodulators in Burns. J. Trauma 1983; 23: 816
   PubMedGoogle Scholar
• Walker H. L., Mason A. D. A Standard Animal Burn. J. Trauma 1968; 8: 1049
   PubMed Web of Science ®Google Scholar
• Woda B. A., McFadden' M., Welsch R. M., Bain K. M. Separation and Isolation of Rat Natural Killer Cells from T Cells with Monoclonal Antibodies. J. Immunol. 1984; 132: 2183
   PubMed Web of Science ®Google Scholar
• Feller I., Pierson C. Pseudomonas Vaccine and Hyperimmune Plasma for Burned Patients. Arch. Surg. 1968; 97: 225
   PubMedGoogle Scholar
• Stinnett J. D., Loose L. D., Misbell P., Tenney C. L., Gonce S. J., Alexander J. W. Synthetic Immunomodulators for Preservation of Fatal Infections in a Burned Guinea Pig Model. Ann. Surg. 1983; 198: 53
   PubMed Web of Science ®Google Scholar
• Hansbrough J. F., Zapata-Sirvent R. L., Peterson V. M. Immunomodulation following Burn Injury. Surgical Clin. North Am. 1987; 67: 69
   PubMedGoogle Scholar
• Zapata-Sirvent R. L., Hansbrough J. F. Post Burn Immunosuppression in an Animal Model: III. Maintenance of Normal Splenic Helper and Suppressor Lymphocyte Subpopulations by Immunomodulating Drugs. Surgery 1985; 97: 721
   PubMedGoogle Scholar
• Ninnemann J. L. Immunologic Defenses against Infections: Alterations following Thermal Injuries. J. Burn Care Rehab. 1982; 3: 355
   Google Scholar
• Nakamura T., Miyasaka N., Pope R. M., Talal N., Russell I. J. Immunomodulations by Isoprinosine: Effect on in vitro Immune Functions of Lymphocytes from Humans with Autoimmune Disease. Clin. Exp. Immunol. 1983; 52: 67
   PubMedGoogle Scholar
• Pasino M., Bellone M., Cornaglia P., Tonini G. P., Massino L. Methisoprinol Effect on Enriched B and T Lymphocytes Populations Stimulated with Phytohemagglutinins. J. Immunopharraacol. 1982; 4: 101
   PubMed Web of Science ®Google Scholar
• Fischbach M., Talyal N. Restoration of Interleukin-2 production and Immune Function in Autoimmune Mice. Clin. Exp. Immunol. 1985; 61: 242
   PubMedGoogle Scholar
• Bekesi J. G., Tsang P. H., Wallace J. I., Roboz J. P. Immunorestorative Properties of Isoprinosine in the Treatment of Patients at High Risk of Developing ARC or AIDS. J. Clin. Lab. Immunol. 1987; 24: 155
   PubMedGoogle Scholar
• Wybran J., Appleboom T. Isoprinosine (Inosiplex) Immunological and Clinical Effects. Immunomodulation: New Frontiers and Advances, H. H. Fudenberg, H. D. Whitten. Plenum Press, New York 1984; 363
   Google Scholar
• Silvennoinen-Kassinen S., Kastunen R., Tiilikainen A., Huttunen K. Isoprinosine Enhances PHA Responses and has Potential Effects on Natural Killer Cell (NK) Activity of Uremic Patients in vitro. Nephron 1987; 46: 243
   PubMedGoogle Scholar